Quanta presents QTX3034 monotherapy data in advanced endometrial cancer
Quanta presented monotherapy data for QTX3034 in KRAS G12D-mutant advanced endometrial cancer at the EORTC-NCI-AACR Symposium.
Quanta presented monotherapy data for QTX3034 in KRAS G12D-mutant advanced endometrial cancer at the EORTC-NCI-AACR Symposium.